Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study

BACKGROUND: In nonvalvular atrial fibrillation (AF), oral anticoagulants prevent ischemic strokes and transient ischemic attacks (TIAs), but nonpersistence with vitamin K antagonist (VKA) oral anticoagulant therapy (20–50% at 1 year) is problematic. The precise risk of stroke/TIA after VKA cessation...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Am Heart Assoc
Asıl Yazarlar: Martinez, Carlos, Wallenhorst, Christopher, Rietbrock, Stephan, Freedman, Ben
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7033838/
https://ncbi.nlm.nih.gov/pubmed/31937194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.014376
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller